Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds

Microvascular Research

Volumn 90, Issue , 2013, Pages 71-79

  Kampmann, Andreas ^a   Lindhorst, Daniel ^a   Schumann, Paul ^a   Zimmerer, Rüdiger ^a   Kokemüller, Horst ^a   Rücker, Martin ^a   Gellrich, Nils Claudius ^a   Tavassol, Frank ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGLACTIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CAPILLARY DENSITY; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; LEUKOCYTE ACTIVATION; LEUKOCYTE ROLLING; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEAR RATE; TISSUE ENGINEERING; VEIN DIAMETER;

MUS;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BLOOD FLOW VELOCITY; CELL HYPOXIA; CELL SURVIVAL; FEMALE; KINETICS; LACTIC ACID; LEUKOCYTE ROLLING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; POLYGLYCOLIC ACID; REGIONAL BLOOD FLOW; SKIN; SOLUBILITY; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888436408     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.07.006     Document Type: Article

References (46)

1. Alhag M., et al. Evaluation of early healing events around mesenchymal stem cell-seeded collagen - glycosaminoglycan scaffold. An experimental study in Wistar rats. Oral Maxillofac. Surg. 2011, 15:31-39.
2. Boukhechba F., et al. Fate of bone marrow stromal cells in a syngenic model of bone formation. Tissue Eng. Part A 2011, 17:2267-2278.
3. Carvalho C., et al. Fabrication of soft and hard biocompatible scaffolds using 3DBioplottingTM. Virtual Modeling and Rapid Manufacturing - Advanced Research in Virtual and Rapid Prototyping 2005, 97-102. Taylor & Francis Group, London. P.J. Bártolo (Ed.).
4. Chang S.C.-N., et al. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation. Artif. Organs. 2009, 33:301-308.
5. da Silva Meirelles L., Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br. J. Haematol. 2003, 123:702-711.
6. Duffy G.P., et al. Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng. Part A 2009, 15:2459-2470.
7. Egaña J.T., et al. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng. Part A 2009, 15:1191-1200.
8. Estrada R., et al. Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J. Cell. Physiol. 2009, 219:563-571.
9. Geiger F., et al. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 2007, 41:516-522.
10. Giannoni P., et al. Short-time survival and engraftment of bone marrow stromal cells in an ectopic model of bone regeneration. Tissue Eng. Part A 2009, 16:489-499.
11. He J., et al. Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng. Part A 2012, 18:1520-1528.
12. Helmlinger G., et al. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat. Med. 1997, 3:177-182.
13. Hernández A., et al. In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system. J. Biomed. Mater. Res. A 2012, 100A:2382-2391.
14. Hoffmann J., et al. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. Thorac. Cardiovasc. Surg. 2010, 58:136,142.
15. Huang Y.-C., et al. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 2005, 20:848-857.
16. Kagiwada H., et al. Human mesenchymal stem cells as a stable source of VEGF-producing cells. J. Tissue Eng. Regen. Med. 2008, 2:184-189.
17. Kaigler D., et al. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J. Bone Miner. Res. 2006, 21:735-744.
18. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur. Cell. Mater. 2008, 15:100-114.
19. Karayiannakis A.J., et al. Serum and drainage fluid vascular endothelial growth factor levels in early surgical wounds. Eur. Surg. Res. 2003, 35:492-496.
20. Kleinheinz J., et al. Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model. Head Face Med. 2010, 6:17.
21. Koob S., et al. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects. Tissue Eng. Part A 2010, 17:311-321.
22. Kretlow J.D., et al. Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects. Tissue Eng. Part A 2010, 16:3555-3568.
23. Kruger E.A., et al. In vitro mineralization of human mesenchymal stem cells on three-dimensional type I collagen versus PLGA scaffolds: a comparative analysis. Plast. Reconstr. Surg. 2011, 127:2301-2311.
24. Lehr H.A., et al. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am. J. Pathol. 1993, 143:1055-1062.
25. Lim J.Y., et al. Optimizing the osteogenic potential of adult stem cells for skeletal regeneration. J. Orthop. Res. 2011, 29:1627-1633.
26. Lindhorst D., et al. Effects of VEGF loading on scaffold-confined vascularization. J. Biomed. Mater. Res. A 2010, 95A:783-792.
27. Ma T. Mesenchymal stem cells: From bench to bedside. World J. Stem Cells 2010, 2:13-17.
28. Malda J., et al. Oxygen gradients in tissue-engineered Pegt/Pbt cartilaginous constructs: measurement and modeling. Biotechnol. Bioeng. 2004, 86:9-18.
29. Melero-Martin J.M., et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 2008, 103:194-202.
30. Nagai N., et al. Preparation and characterization of collagen microspheres for sustained release of VEGF. J. Mater. Sci. Mater. Med. 2010, 21:1891-1898.
31. Naito H., et al. The effect of mesenchymal stem cell osteoblastic differentiation on the mechanical properties of engineered bone-like tissue. Tissue Eng. Part A 2011, 17:2321-2329.
32. Peng H., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. 2002, 110:751-759.
33. Peng H., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J. Bone Miner. Res. 2005, 20:2017-2027.
34. Reyes R., et al. Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect. Injury 2012, 43:334-342.
35. Rucker M., et al. Vascularization and biocompatibility of scaffolds consisting of different calcium phosphate compounds. J. Biomed. Mater. Res. A 2008, 86:1002-1011.
36. Schantz J.-T., et al. Repair of calvarial defects with customised tissue-engineered bone grafts II. Evaluation of cellular efficiency and efficacy in vivo. Tissue Eng. 2003, 9:127-139.
37. Schumann P., et al. Consequences of seeded cell type on vascularization of tissue engineering constructs in vivo. Microvasc. Res. 2009, 78:180-190.
38. Seebach C., et al. Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng. Part A 2010, 16:1961-1970.
39. Singh S., et al. Delivery of VEGF using collagen-coated polycaprolactone scaffolds stimulates angiogenesis. J. Biomed. Mater. Res. A 2012, 100A:720-727.
40. Tavassol F., et al. Accelerated angiogenic host tissue response to poly(l-lactide-co-glycolide) scaffolds by vitalization with osteoblast-like cells. Tissue Eng. Part A 2010, 16:2265-2279.
41. Tavassol F., et al. Prolongated survival of osteoblast like cells (OLC) on biodegradable scaffolds by heat shock preconditioning. Tissue Eng. Part A 2011, 17:1935-1943.
42. Trojani C., et al. Ectopic bone formation using an injectable biphasic calcium phosphate/Si-HPMC hydrogel composite loaded with undifferentiated bone marrow stromal cells. Biomaterials 2006, 27:3256-3264.
43. Wernike E., et al. VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. Eur. Cell. Mater. 2010, 19:30-40.
44. Xie J., et al. Induction of angiogenesis by controlled delivery of VEGF using nanoparticles. Cardiovasc. Ther. 2012, 31:e12-e18.
45. Zhao M., et al. Repair of bone defect with vascularized tissue engineered bone graft seeded with mesenchymal stem cells in rabbits. Microsurgery 2011, 31:130-137.
46. Zhou S., et al. Nutrient gradients in engineered cartilage: Metabolic kinetics measurement and mass transfer modelling. Biotechnol. Bioeng. 2008, 101:408-421.